Shenzhen Hepalink Pharmaceutical Group , Ltd. Goodwill

As of the most recent data (June 2026), SHEZF shows a goodwill of $2.2B. That compares with $2.3B in the prior-year period — down 4.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SHEZF's goodwill is now $2.2B (was $2.3B) — a 4.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Shenzhen Hepalink Pharmaceutical Group , Ltd. is outperforming or lagging.

Tracking SHEZF's goodwill over time shows whether Shenzhen Hepalink Pharmaceutical Group , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $2.2B That compares with $2.3B in the prior-year period — down 4.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Shenzhen Hepalink Pharmaceutical Group , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $2.2B) with ownership activity and broader fundamentals.